" class="no-js "lang="en-US"> Advent France Biotechnology - Medtech Alert
Saturday, September 20, 2025
Advent France Biotechnology | Pharmtech Focus

Advent France Biotechnology

About Advent France Biotechnology

Advent France Biotechnology

Advent France Biotechnology focuses on ground-breaking innovations in Life Sciences to address unmet medical and clinical needs, building the next generation of pioneering healthcare companies. Keeping in mind patients’ well-being, we believe in improving medical care and taking medical innovations further ahead.

We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and drive inventive Life Sciences start-ups to success.

We embrace French Life Sciences’ dynamic of innovation. France harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. Advent France Biotechnology seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring France’s biotechnology ecosystem. With Advent France Biotechnology Seed Fund I, we stand as the first dedicated Life Sciences seed-fund in France.

Advent France Biotechnology was founded in 2015 and is AMF regulated since 2016.

Related Story

Advent France Biotechnology Launches its Second Fund with a First Close at €86M ($102M)

September 30 2021

Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, today announces the […]

Advent France Biotechnology (AFB) Appoints Sidonie Fabre as CFO

June 8 2021

Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, today announces the […]